PURE
PURE Bioscience, Inc. engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. It offers silver dihydrogen citrate-based disinfecting and sanitizing products. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in El Cajon, CA.
PURE BIOSCIENCE, INC. (PURE) is rated C+ (2.5/5) on Deltasharpe Prism, scored against General sector peers. Its strongest pillar is Growth (A+); its weakest is Profitability (D-).
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2023-07-31 | C+ (2.8) | A+ (4.9) | D- (1.1) | C (2.5) | D (1.3) | C+ (2.5) |
| 2023-04-30 | C+ (2.7) | F (0.3) | D (1.3) | C (2.5) | C+ (2.5) | C- (1.9) |
| 2023-01-31 | C+ (2.7) | D (1.3) | D- (0.9) | C (2.5) | C+ (2.5) | C- (2.0) |
| 2022-10-31 | C+ (2.8) | D (1.2) | D+ (1.6) | C (2.5) | C+ (2.5) | C- (2.1) |
| 2022-07-31 | C+ (2.8) | F (0.0) | D- (1.1) | C (2.5) | D (1.4) | D+ (1.6) |